image
Replimune Group, Inc. REPL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.4
-1.57 %
$ 725 M
Market Cap
-3.06
P/E
Price Target Average
106.69%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
20.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Replimune Group, Inc.
image
Wall Street analysts predict an average 1-year price target for REPL of $19.4 , with forecasts ranging from a low of $13 to a high of $27 .
REPL Lowest Price Target Wall Street Target
13 USD 38.30%
REPL Average Price Target Wall Street Target
19.4 USD 106.69%
REPL Highest Price Target Wall Street Target
27 USD 187.23%
Price
Max Price Target
Min Price Target
Average Price Target
3030252520201515101055Jul '24Jul '2420252025Jul '25Jul '2520262026Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart REPL

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart REPL

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart REPL

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202420242025202520262026202720272028202820292029